Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study 08/09/2022 14:58 Smith et.al.; Journal of Crohn's and Colitis, 2022 Sep 8;16(9):1436-1446 קרא עוד ←
